These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36502788)
21. Salidroside improves cognitive function in Parkinson's disease via Braf-mediated mitogen‑activated protein kinase signaling pathway. Lu S; Ji N; Wang W; Lin X; Gao D; Geng D Biomed Pharmacother; 2024 Aug; 177():116968. PubMed ID: 38901199 [TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model. Yang W; Chen YH; Liu H; Qu HD Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012 [TBL] [Abstract][Full Text] [Related]
23. Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease. Wu DM; Han XR; Wen X; Wang S; Fan SH; Zhuang J; Wang YJ; Zhang ZF; Li MQ; Hu B; Shan Q; Sun CH; Lu J; Zheng YL Cell Physiol Biochem; 2018; 46(5):1793-1806. PubMed ID: 29705802 [TBL] [Abstract][Full Text] [Related]
24. LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/β-CATENIN pathway. Yang JM; Huang HM; Cheng JJ; Huang CL; Lee YC; Chiou CT; Huang HT; Huang NK; Yang YC Toxicology; 2018 Dec; 410():65-72. PubMed ID: 30205152 [TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system. Guo Z; Xu S; Du N; Liu J; Huang Y; Han M Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716 [TBL] [Abstract][Full Text] [Related]
26. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease. Marchetti B Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246 [TBL] [Abstract][Full Text] [Related]
27. Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway. Yue Y; Qiao B; Jiang X Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):32-36. PubMed ID: 32359380 [TBL] [Abstract][Full Text] [Related]
28. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats. Singh S; Mishra A; Shukla S Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802 [TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease. Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150 [TBL] [Abstract][Full Text] [Related]
30. Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation. Vallée A; Vallée JN; Lecarpentier Y Aging (Albany NY); 2021 Apr; 13(7):10796-10813. PubMed ID: 33848261 [TBL] [Abstract][Full Text] [Related]
31. Silencing RNF13 Alleviates Parkinson's Disease - Like Problems in Mouse Models by Regulating the Endoplasmic Reticulum Stress-Mediated IRE1α-TRAF2-ASK1-JNK Pathway. Ji M; Niu S; Guo J; Mi H; Jiang P J Mol Neurosci; 2020 Dec; 70(12):1977-1986. PubMed ID: 32617872 [TBL] [Abstract][Full Text] [Related]
32. Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's disease model mice. Zhu J; Gao W; Shan X; Wang C; Wang H; Shao Z; Dou S; Jiang Y; Wang C; Cheng B Brain Res; 2020 Jan; 1726():146493. PubMed ID: 31586624 [TBL] [Abstract][Full Text] [Related]
33. l-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease. Raj K; Gupta GD; Singh S Drug Chem Toxicol; 2022 Sep; 45(5):2097-2108. PubMed ID: 34210222 [TBL] [Abstract][Full Text] [Related]
34. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways. Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476 [TBL] [Abstract][Full Text] [Related]
35. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress. Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919 [TBL] [Abstract][Full Text] [Related]
36. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice. Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132 [TBL] [Abstract][Full Text] [Related]
37. Mulberrin attenuates 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced Parkinson's disease by promoting Wnt/β-catenin signaling pathway. Cao W; Dong Y; Zhao W; Lu X; Sun L J Chem Neuroanat; 2019 Jul; 98():63-70. PubMed ID: 30978489 [TBL] [Abstract][Full Text] [Related]
38. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression. Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562 [TBL] [Abstract][Full Text] [Related]
39. Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease. Ruan S; Xie J; Wang L; Guo L; Li Y; Fan W; Ji R; Gong Z; Xu Y; Mao J; Xie J Front Pharmacol; 2023; 14():1088957. PubMed ID: 36817162 [No Abstract] [Full Text] [Related]
40. Depletion of canonical Wnt signaling components has a neuroprotective effect on midbrain dopaminergic neurons in an MPTP-induced mouse model of Parkinson's disease. Dai TL; Zhang C; Peng F; Niu XY; Hu L; Zhang Q; Huang Y; Chen L; Zhang L; Zhu W; Ding YQ; Song NN; Liao M Exp Ther Med; 2014 Aug; 8(2):384-390. PubMed ID: 25009587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]